Vitro Biopharma, Inc. Quarterly Operating Margin in % from Q3 2023 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Vitro Biopharma, Inc. quarterly/annual Operating Margin history and growth rate from Q3 2023 to Q4 2024.
  • Vitro Biopharma, Inc. Operating Margin for the quarter ending January 31, 2025 was -326 %, a 34.1% increase year-over-year.
  • Vitro Biopharma, Inc. annual Operating Margin for 2024 was -493 %, a 61.6% decline from 2023.
  • Vitro Biopharma, Inc. annual Operating Margin for 2023 was -305 %.
  • Vitro Biopharma, Inc. annual Operating Margin for 2015 was -203 %, a 42.3% decline from 2014.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -326 +168 +34.1% Nov 1, 2024 Jan 31, 2025
Q3 2024 -493 -188 -61.6% Aug 1, 2024 Oct 31, 2024
Q2 2024 -481 May 1, 2024 Jul 31, 2024
Q1 2024 -412 Feb 1, 2024 Apr 30, 2024
Q4 2023 -494 Nov 1, 2023 Jan 31, 2024
Q3 2023 -305 Aug 1, 2023 Oct 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.